Pacific Shuanglin Bio-pharmacy Co., LTD — Investor Relations & Filings
Pacific Shuanglin Bio-pharmacy Co., LTD specializes in the research, development, production, and distribution of plasma-derived medicinal products. The company operates a comprehensive value chain encompassing plasma collection, fractionation, and the manufacturing of critical biopharmaceuticals. Its core product portfolio includes human albumin, intravenous human immunoglobulin (IVIG), coagulation factor VIII, and various specialized immunoglobulins such as tetanus and hepatitis B human immunoglobulins. Utilizing advanced protein separation and purification technologies, the company provides essential treatments for immune deficiencies, coagulation disorders, and critical care scenarios. Pacific Shuanglin maintains a network of plasma collection centers and adheres to rigorous quality control standards to ensure the safety and efficacy of its biological products for clinical use.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 关于公司控股股东股份解除质押的公告 | 2026-04-28 | Chinese | |
| 关于部分董事、高级管理人员对定期报告有异议的说明公告 | 2026-04-28 | Chinese | |
| 2025年度非经营性资金占用及其他关联资金往来情况汇总表 | 2026-04-28 | Chinese | |
| 关于归还暂时补充流动资金的闲置募集资金的公告 | 2026-04-14 | Chinese | |
| 关于部分募集资金专户完成销户的公告 | 2026-04-14 | Chinese | |
| 关于子公司收到静注人免疫球蛋白及人凝血因子IX药品注册核查通知的公告 | 2026-04-13 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 42059603 | 关于公司控股股东股份解除质押的公告 | 2026-04-28 | Chinese | ||
| 42059598 | 关于部分董事、高级管理人员对定期报告有异议的说明公告 | 2026-04-28 | Chinese | ||
| 42059586 | 2025年度非经营性资金占用及其他关联资金往来情况汇总表 | 2026-04-28 | Chinese | ||
| 34893263 | 关于归还暂时补充流动资金的闲置募集资金的公告 | 2026-04-14 | Chinese | ||
| 34859290 | 关于部分募集资金专户完成销户的公告 | 2026-04-14 | Chinese | ||
| 42059571 | 关于子公司收到静注人免疫球蛋白及人凝血因子IX药品注册核查通知的公告 | 2026-04-13 | Chinese | ||
| 42059570 | 关于全资子公司获得药物临床试验批准通知书的公告 | 2026-04-12 | Chinese | ||
| 42059565 | 第十届董事会第二十一次会议（临时会议）决议公告 | 2026-03-30 | Chinese | ||
| 42059564 | 北京市嘉源律师事务所关于派斯双林生物制药股份有限公司2026年第一次临时股东会的法律意见书 | 2026-03-23 | Chinese | ||
| 42059559 | 2026年第一次临时股东会决议公告 | 2026-03-23 | Chinese | ||
| 42059550 | 关于变更签字注册会计师的公告 | 2026-03-17 | Chinese | ||
| 42059544 | 关于使用暂时闲置的募集资金进行现金管理的公告 | 2026-03-06 | Chinese | ||
| 42059539 | 关于签订《战略合作协议之补充协议三》的公告 | 2026-03-06 | Chinese | ||
| 42059528 | 关于召开2026年第一次临时股东会的通知 | 2026-03-06 | Chinese | ||
| 42059526 | 关于使用闲置募集资金暂时补充流动资金的公告 | 2026-03-06 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Pacific Shuanglin Bio-pharmacy Co., LTD via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/53611/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=53611 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=53611 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=53611 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 53611}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Pacific Shuanglin Bio-pharmacy Co., LTD (id: 53611)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.